Women's Sexual Wellness, Built for Women

OmniRx Health offers discreet, evidence-based women's sexual-wellness care via telehealth. We evaluate and treat low libido, hypoactive sexual desire disorder (HSDD), perimenopause, painful intercourse, vaginal dryness, hot flashes, and hormone-driven sleep and mood changes — with clinicians who actually listen and treatment shipped discreetly to your door.

What We Treat

  • Menopausal Hormone Therapy (MHT): Transdermal estradiol with cyclic or continuous progesterone for women with a uterus, targeting hot flashes, sleep, mood, and libido.
  • Low-Dose Testosterone for Women: An off-label, guideline-supported option for HSDD and persistent low desire, carefully titrated from baseline labs with quarterly monitoring.
  • Vaginal Estrogen & DHEA: Local therapy for genitourinary symptoms — dryness, burning, and painful intercourse — with very low systemic absorption.
  • Flibanserin (Addyi) & Bremelanotide (Vyleesi): FDA-approved medications for HSDD that target the central neurochemistry of desire.
  • Ospemifene & Non-Hormonal Options: For women who can't or don't want systemic hormones, including support for sleep, mood, and libido.

How It Works

Step 1: Complete a focused intake and meet a state-licensed provider over video. Step 2: Complete baseline labs — estradiol, FSH, total and free testosterone, SHBG, DHEA-S, TSH, and prolactin — drawn at a Quest or LabCorp near you. Step 3: Receive an individualized plan, with prescriptions sent to your pharmacy or shipped discreetly, plus follow-up at 6–8 weeks then quarterly.

Frequently Asked Questions

Who is this for?
Adult women — premenopausal, perimenopausal, and postmenopausal — dealing with low libido, HSDD, painful intercourse, vaginal dryness, hot flashes, sleep disruption, or hormone-driven mood and intimacy concerns.
Do I need bloodwork to start?
Yes. A baseline panel helps choose the right treatment, and we help arrange the draw at a Quest or LabCorp location near you.
Is testosterone for women safe and legal?
Low-dose testosterone for women is used off-label in the U.S. and is supported by international guidelines for postmenopausal HSDD, prescribed at carefully titrated doses with follow-up monitoring.
Which states do you serve?
We currently offer dedicated women's sexual-wellness intake in Alaska, Arkansas, Illinois, Massachusetts, Michigan, New Mexico, North Carolina, Ohio, Oregon, Pennsylvania, and South Carolina, with broader coverage rolling out.